The ₹2,000-Crore Upgrade: Jubilant Ingrevia’s New Growth Formula

Jubilant Ingrevia, a part of the Jubilant Bhartia Group, is beginning to witness early gains from its nearly ₹2,000-crore investment programme focused on specialty chemicals, contract development and manufacturing (CDMO), and nutrition ingredients, as the company accelerates its transition away from cyclical commodity chemicals toward higher-margin specialty businesses.

The company said it has invested more than ₹2,000 crore over the past two years in establishing new manufacturing facilities, upgrading technologies and expanding specialty chemical capabilities. The investments include agro-CDMO operations, semiconductor chemistry infrastructure and multi-purpose specialty chemical plants.

According to the management, the investment phase will continue through FY27, with plans for further expansion of the multi-purpose manufacturing plant at Gajraula, scaling up semiconductor-focused research and development infrastructure, and continued deployment in advanced technologies such as flow chemistry and cryogenic systems.

The company said its long-term strategy aligns with a broader trend in the chemical industry, where manufacturers are increasingly focusing on specialty and innovation-driven businesses to improve profitability and reduce dependence on volatile commodity chemical markets.

News by Rahul Yelligetti.